Capital Fund Management S.A. Invests $7.11 Million in Teleflex Incorporated $TFX

Key Points

• Capital Fund Management S.A. purchased a new stake in Teleflex Incorporated, acquiring 51,436 shares valued at approximately $7.1 million, representing about 0.12% of the company.
• Wall Street analysts have given Teleflex a consensus rating of "Hold", with an average price target of $141.57, reflecting mixed sentiments from recent research reports.
• The company reported a $3.73 EPS for the last quarter, exceeding forecasts, and announced a quarterly dividend of $0.34 per share, set to be paid on September 15th.

Capital Fund Management S.A. acquired a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 51,436 shares of the medical technology company's stock, valued at approximately $7,108,000. Capital Fund Management S.A. owned 0.12% of Teleflex as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the business. Humankind Investments LLC increased its stake in shares of Teleflex by 11.4% during the 1st quarter. Humankind Investments LLC now owns 1,586 shares of the medical technology company's stock worth $219,000 after purchasing an additional 162 shares during the last quarter. Groupama Asset Managment acquired a new position in shares of Teleflex during the 1st quarter worth $250,000. Quantbot Technologies LP increased its stake in shares of Teleflex by 86.5% during the 1st quarter. Quantbot Technologies LP now owns 52,610 shares of the medical technology company's stock worth $7,270,000 after purchasing an additional 24,400 shares during the last quarter. Qtron Investments LLC increased its stake in shares of Teleflex by 65.2% during the 1st quarter. Qtron Investments LLC now owns 3,140 shares of the medical technology company's stock worth $434,000 after purchasing an additional 1,239 shares during the last quarter. Finally, Brooklyn Investment Group increased its stake in shares of Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock worth $29,000 after purchasing an additional 150 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Price Performance

TFX traded down $0.26 during midday trading on Tuesday, reaching $127.29. 477,949 shares of the company's stock were exchanged, compared to its average volume of 787,642. The firm has a market capitalization of $5.63 billion, a price-to-earnings ratio of 29.95, a price-to-earnings-growth ratio of 1.80 and a beta of 1.08. The business has a 50-day simple moving average of $118.28 and a two-hundred day simple moving average of $130.03. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. Teleflex Incorporated has a one year low of $108.90 and a one year high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping the consensus estimate of $3.36 by $0.37. The company had revenue of $780.90 million during the quarter, compared to analyst estimates of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company's revenue was up 4.2% on a year-over-year basis. During the same quarter last year, the business posted $3.42 earnings per share. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. Teleflex's dividend payout ratio (DPR) is currently 32.00%.

Analyst Ratings Changes

Several research analysts have recently commented on TFX shares. Mizuho increased their price target on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research note on Friday, August 1st. Wells Fargo & Company decreased their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. Royal Bank Of Canada upped their price target on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a report on Friday, August 1st. Truist Financial decreased their price target on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a report on Monday, May 5th. Finally, Wall Street Zen upgraded shares of Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. One analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Teleflex currently has a consensus rating of "Hold" and a consensus target price of $141.57.

Insiders Place Their Bets

In related news, Director Stuart A. Randle purchased 1,000 shares of the stock in a transaction that occurred on Tuesday, August 5th. The stock was acquired at an average price of $115.86 per share, with a total value of $115,860.00. Following the completion of the acquisition, the director directly owned 7,547 shares in the company, valued at approximately $874,395.42. This trade represents a 15.27% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Andrew A. Krakauer purchased 1,000 shares of the stock in a transaction that occurred on Tuesday, August 5th. The stock was bought at an average cost of $115.25 per share, with a total value of $115,250.00. Following the acquisition, the director owned 7,192 shares of the company's stock, valued at $828,878. This represents a 16.15% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 5,500 shares of company stock valued at $633,590 over the last quarter. Company insiders own 1.40% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.